Jupiter Research Capital (Asia) Ltd’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
Jupiter Research Capital (Asia) Ltd's MDGL Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2026, closing a stake of 6,451 shares — an estimated $3.46M sold.
Jupiter Research Capital (Asia) Ltd first reported a position in MDGL in Q1 2026 and held it in 2 quarters. The position peaked at $3.46M in Q2 2026. 407 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd reported no remaining Madrigal Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Jupiter Research Capital (Asia) Ltd sold 6,451 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $3.46M.
- Jupiter Research Capital (Asia) Ltd first reported a position in Madrigal Pharmaceuticals in Q1 2026 and held it in 2 quarters.
- Jupiter Research Capital (Asia) Ltd's Madrigal Pharmaceuticals position peaked at $3.46M in Q2 2026.
- 407 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.